The NSABP Study of Tamoxifen and Raloxifene (STAR) trial
Raloxifene vs. Tamoxifen: Breast Cancer and Other Outcomes in the STAR Trial
NEJM Journal Watch
0 comment
No comments yet. Be the first!
View less